APA-viite

van der Meulen, M., Zamanipoor Najafabadi, A. H., Lobatto, D. J., Andela, C. D., Vliet Vlieland, T. P. M., Pereira, A. M., . . . Biermasz, N. R. (2020). SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements. Endocrine.

Chicago-tyylinen lähdeviittaus

van der Meulen, Merel, Amir H. Zamanipoor Najafabadi, Daniel J. Lobatto, Cornelie D. Andela, Thea P. M. Vliet Vlieland, Alberto M. Pereira, Wouter R. van Furth, ja Nienke R. Biermasz. "SF-12 or SF-36 in Pituitary Disease? Toward Concise and Comprehensive Patient-reported Outcomes Measurements." Endocrine 2020.

MLA-viite

van der Meulen, Merel, et al. "SF-12 or SF-36 in Pituitary Disease? Toward Concise and Comprehensive Patient-reported Outcomes Measurements." Endocrine 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.